An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
for Biliary Atresia
10 locations incl. Aurora
Sponsor: Albireo, an Ipsen Company
Sex: All·Age: All ages
Code: NCT05426733·Phase 3·Enrolling By Invitation